Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis.
Adult
Aged
Aged, 80 and over
Amyloidosis
/ complications
Cardiomyopathy, Dilated
/ complications
Cardiomyopathy, Hypertrophic
/ complications
Case-Control Studies
Early Diagnosis
Female
Heart Failure
/ diagnostic imaging
Humans
Magnetic Resonance Imaging, Cine
Male
Middle Aged
Predictive Value of Tests
Prognosis
Risk Assessment
Risk Factors
Stroke Volume
Ventricular Function, Left
Ventricular Function, Right
Young Adult
Cardiac magnetic resonance
Fast-strain-encoded MR (fast-SENC)
Heart failure
Hypertrophy
Ischemic and non-ischemic cardiomyopathies
Late gadolinium enhancement
Myocarditis
Journal
Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
ISSN: 1532-429X
Titre abrégé: J Cardiovasc Magn Reson
Pays: England
ID NLM: 9815616
Informations de publication
Date de publication:
05 04 2021
05 04 2021
Historique:
received:
16
11
2019
accepted:
20
01
2021
entrez:
7
4
2021
pubmed:
8
4
2021
medline:
17
8
2021
Statut:
epublish
Résumé
To compare the ability of left ventricular (LV) and right ventricular (RV) strain measured by fast-strain encoded cardiovascular magnetic resonance (CMR) (fast-SENC) with LV- and RV-ejection fraction for the diagnostic classification of patients with different stages of chronic heart failure (stages A-D based on American College of Cardiology/American Heart Association guidelines) due to non-ischemic cardiomyopathies. Our study population consisted of 276 consecutive patients who underwent CMR for clinical reasons, and 19 healthy subjects. Wall motion score index and non-infarct related late gadolinium enhancement (LGE), LV ejection fraction (LVEF) and RV ejection fraction (RVEF) and global LV- and RV-longitudinal (GLS) and circumferential strain (GCS) based on fast-SENC acquisitions, were calculated in all subjects. The percentage of LV and RV myocardial segments with strain ≤ - 17% (%normal LV and RV myocardium) was determined in all subjects. LVEF and RVEF, LV-GLS, LV-GCS, RV-GLS, RV-GCS and %normal LV- and RV myocardium depressed with increasing heart failure stage (p < 0.001 for all by ANOVA). By multivariable analysis, %normal LV and RV myocardium exhibited closer associations to heart failure stages than LVEF and RVEF (r In patients with non-ischemic cardiomyopathy, %normal LV and RV myocardium, by fast-SENC, enables improved identification of asymptomatic patients with subclinical LV-dysfunction. This technique may be useful for the early identification of such presumably healthy subjects at risk for heart failure and for monitoring LV and RV deformation during pharmacologic interventions in future studies.
Identifiants
pubmed: 33823860
doi: 10.1186/s12968-021-00711-w
pii: 10.1186/s12968-021-00711-w
pmc: PMC8025329
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
45Références
Eur J Heart Fail. 2013 Jun;15(6):660-70
pubmed: 23475781
Circ Cardiovasc Imaging. 2009 Mar;2(2):116-22
pubmed: 19808577
Lancet. 2010 Feb 27;375(9716):752-62
pubmed: 20189027
J Am Coll Cardiol. 1998 Oct;32(4):948-54
pubmed: 9768716
J Am Coll Cardiol. 2007 Jun 26;49(25):2419-26
pubmed: 17599605
JACC Cardiovasc Imaging. 2016 Feb;9(2):126-38
pubmed: 26777222
Am J Hematol. 2005 Aug;79(4):319-28
pubmed: 16044444
Heart. 2011 May;97(9):727-32
pubmed: 21097819
Lancet. 2017 Jul 22;390(10092):400-414
pubmed: 28190577
Clin Cardiol. 2007 May;30(5):245-50
pubmed: 17492679
Int J Cardiol. 2013 Jun 5;166(1):85-9
pubmed: 22071039
Circ Res. 2017 Sep 15;121(7):722-730
pubmed: 28912179
ESC Heart Fail. 2019 Aug;6(4):584-602
pubmed: 31021534
Circ Cardiovasc Imaging. 2009 Mar;2(2):132-40
pubmed: 19808579
Circulation. 1996 Mar 1;93(5):841-2
pubmed: 8598070
Int J Cardiol. 2017 Dec 15;249:467-472
pubmed: 29121751
Circulation. 2006 Apr 11;113(14):1807-16
pubmed: 16567565
J Am Coll Cardiol. 2006 Nov 21;48(10):1977-85
pubmed: 17112987
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):307-15
pubmed: 25246506
JACC Cardiovasc Imaging. 2018 Oct;11(10):1419-1429
pubmed: 29361479
Eur Heart J. 2008 Jan;29(2):270-6
pubmed: 17916581
J Am Coll Cardiol. 2014 Jul 8;64(1):83-99
pubmed: 24998133
J Am Coll Cardiol. 1995 Apr;25(5):1143-53
pubmed: 7897128
Circulation. 2013 Oct 8;128(15):1623-33
pubmed: 23965488
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7):
pubmed: 28655709
Int J Cardiol Heart Vasc. 2018 Mar 06;18:46-51
pubmed: 29876503
J Am Coll Cardiol. 2008 Jan 15;51(2):149-57
pubmed: 18191740
Lancet. 2016 Jun 25;387(10038):2641-2654
pubmed: 26719234
Circ Heart Fail. 2013 May;6(3):606-19
pubmed: 23616602
Int J Ayurveda Res. 2010 Jul;1(3):187-91
pubmed: 21170214
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
JAMA. 2002 Mar 13;287(10):1308-20
pubmed: 11886323
J Am Coll Cardiol. 1993 Mar 1;21(3):649-54
pubmed: 8436746
Circulation. 2008 Mar 18;117(11):1436-48
pubmed: 18347220
Circulation. 2002 Jan 29;105(4):539-42
pubmed: 11815441
Heart. 2001 May;85(5):581-9
pubmed: 11303017
J Am Coll Cardiol. 2011 Sep 6;58(11):1140-9
pubmed: 21884952
J Am Soc Echocardiogr. 2000 Jul;13(7):699-706
pubmed: 10887359
Sci Rep. 2018 Sep 20;8(1):14100
pubmed: 30237411
J Am Coll Cardiol. 2003 Nov 5;42(9):1687-713
pubmed: 14607462
Heart. 2014 Apr;100(8):631-8
pubmed: 24368281
J Am Coll Cardiol. 2016 Mar 29;67(12):1399-1409
pubmed: 27012399
Circulation. 2001 Dec 11;104(24):2996-3007
pubmed: 11739319
JAMA. 2013 Mar 6;309(9):896-908
pubmed: 23462786
N Engl J Med. 2000 Apr 13;342(15):1077-84
pubmed: 10760308
Circulation. 2007 Mar 27;115(12):1563-70
pubmed: 17353436